Skip to menu Skip to content Skip to footer
Associate Professor John O'Sullivan
Associate Professor

John O'Sullivan

Email: 

Overview

Background

After completing neurology training at the Royal Brisbane & Women’s Hospital(RBWH) in 1995, A/Prof O’Sullivan completed Fellowships in Movement Disorders at the Austin & Repatriation Medical Centre, Melbourne then the National Hospital for Neurology and Neurosurgery, and Middlesex Hospital in London, UK. He was awarded a doctorate in Medicine from Melbourne University in 2000 for studies into surgery for Parkinson’s disease. He returned to the RBWH in 2001 and set up the Movement Disorders Clinical Service which he directs including botulinum toxin and later Friedreich's ataxia clinics, and co-ordinating the Huntington's disease multidisciplinary clinic. Through these clinics he has established collaborations with local, interstate and international researchers in the fields of Parkinson's disease, and other movement disorders and neurodegenerative diseases. He is currently Associate Professor of Medicine at UQ Centre for Clinical Research, currently co-director of the Neurodegenertion Clinical Research Group. A/Prof O'Sullivan past President of the Movement Disorders Society of Australia and New Zealand (MDSANZ), having previously served as Chair of the MDSANZ Clinical Trials and Research Group. He has been is on the Council of the Australian and New Zealand Association of Neurolgists (ANZAN) and previously chaired the ANZAN Scientific Program Committee.

Availability

Associate Professor John O'Sullivan is:
Available for supervision
Media expert

Research interests

  • Non-motor features of Parkinson's disease

    This research involves studies into depression, anxiety and cognitive function in Parkinson's disease in collaboration with Dr Nadeeka Dissanayaka, Dr Robert Adam, Prof Gerard Byrne, Dr Nancy Pachana & Dr Rodney Marsh

  • Novel compounds and clinical trials in neurodegenerative diseases

    Research involves novel compounds and repurposed drugs for treatment and disease-modification in Parkinson's, Huntington's disease, Friedreich's Ataxia, Progressive Supranuclear Palsy and motor neurone diseases in collaboration with Dr Richard Gordon, A/Prof Trent Woodruff, A/Prof Rob Henderson, Prof Pam McCombe, Dr Robert Adam and Wesley Medical Research.

  • Exercise in Parkinson's disease

    In collaboration with Prof Sandy Brauer, Dr Robyn Lamont, and Wesley Medical Research, studies exploring maintenance of exercise, gait and boxing in Parkinson's disease.

  • Sleep in neurodegenerative diseases

    These studies in collaboration with Dr Simon Smith, Dr Jane Nikles and Wesley Medical Research explore novel aspects involving sleep in Parkinson's, Huntington's and motor neurone diseases and Friedreich's ataxia

Research impacts

A/Prof O’Sullivan’s novel investigator-initiated clinical trial in Parkinson’s disease (PD) (Mov Dis 2007; 22:1543-9) is cited in the American Academy of Neurology Practice Parameters and MDS Evidence Based Medicine Review of Management of Non-motor symptoms in PD. The initial description of syndrome of Dopamine Dysregulation in PD (JNNP 2000; 68:423-428) complicating dopamine replacement therapy in some patients with Parkinson’s disease has led to widespread recognition of the syndrome, and this paper has had more than 400 citations. The Movement Disorders Society revision of the Unified Parkinson’s Disease Rating Scale (MDS–UPDRS) includes a section to address features of the dopamine dysregulation syndrome as a result of this. This research has also contributed to debate about addiction in general (Addiction. 2012;107(2):253).

Works

Search Professor John O'Sullivan’s works on UQ eSpace

241 works between 1988 and 2025

181 - 200 of 241 works

2007

Journal Article

Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease

Schoffer, Kerrie L., Henderson, Robert D., O'Maley, Karen and O'Sullivan, John D. (2007). Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease. Movement Disorders, 22 (11), 1543-1549. doi: 10.1002/mds.21428

Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease

2007

Journal Article

Validity of Hamilton Depression Inventory in Parkinson's disease

Dissanayaka, N. N. W., Sellbach, A., Matheson, S., Marsh, R., Silburn, P. A., O'Sullivan, J. D., Byrne, G. J. and Mellick, G. D. (2007). Validity of Hamilton Depression Inventory in Parkinson's disease. Movement Disorders, 22 (3), 399-403. doi: 10.1002/mds.21309

Validity of Hamilton Depression Inventory in Parkinson's disease

2007

Conference Publication

Increased population of activated T cells in patients after acute ischemic stroke

Yan, J., Greer, J. M., Cavanagh, H., Henderson, R., O'Sullivan, J., Read, S., Etherington, K. and McCombe, P. A. (2007). Increased population of activated T cells in patients after acute ischemic stroke. 37th Annual Scientific Meeting of the Australasian Society for Immunology, Sydney, Australia, 2-6 December 2007.

Increased population of activated T cells in patients after acute ischemic stroke

2007

Conference Publication

A candidate gene study of the serotonin and dopamine transporter genes in relation to depression in Parkinson’s disease

Dissanayaka, N., Silburn, P., O’Sullivan, J. and Mellick G. (2007). A candidate gene study of the serotonin and dopamine transporter genes in relation to depression in Parkinson’s disease. 6th Australian Human Gene Mapping Conference, Brisbane, Australia, 29-31 August 2007.

A candidate gene study of the serotonin and dopamine transporter genes in relation to depression in Parkinson’s disease

2007

Conference Publication

Genetic and non-genetic determinants of depression in the setting of Parkinson's disease

Dissanayaka, N., Silburn, P., O’Sullivan, J. and Mellick, G. (2007). Genetic and non-genetic determinants of depression in the setting of Parkinson's disease. ASMR Queensland Postgraduate Medical Research Student Conference, Brisbane, QLD, Australia, 23 May, 2007.

Genetic and non-genetic determinants of depression in the setting of Parkinson's disease

2007

Conference Publication

A candidate gene study of the serotonin and dopamine transporter genes in relation to depression in Parkinson's disease.

Dissanayaka, N., Silburn, P., O’Sullivan, J. and Mellick, G. (2007). A candidate gene study of the serotonin and dopamine transporter genes in relation to depression in Parkinson's disease.. 2007 Eskitis Institute Graduate Student Symposium, Brisbane, Australia, October, 2007.

A candidate gene study of the serotonin and dopamine transporter genes in relation to depression in Parkinson's disease.

2007

Journal Article

The time course and determinants of temperature within the first 48 h after ischaemic stroke

Wong, A. A., Davis, J. P., Schluter, P. J., Henderson, R. D., O'Sullivan, J. D. and Read, S. J. (2007). The time course and determinants of temperature within the first 48 h after ischaemic stroke. Cerebrovascular Diseases, 24 (1), 104-110. doi: 10.1159/000103124

The time course and determinants of temperature within the first 48 h after ischaemic stroke

2007

Conference Publication

What contributes to depression in the setting of Parkinson's disease?

Dissanayaka, N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P., O’Sullivan, J., Byrne, G. and Mellick, G. (2007). What contributes to depression in the setting of Parkinson's disease?. 4th National Conference on Depression in the Elderly, Sydney, NSW, Australia, 28-29 June, 2007.

What contributes to depression in the setting of Parkinson's disease?

2007

Journal Article

Development and utilization of the patient knowledge questionnaire on Botulinum toxin use in movement disorders

Schoffer, K. L., O'Maley, K. and O'Sullivan, J. D. (2007). Development and utilization of the patient knowledge questionnaire on Botulinum toxin use in movement disorders. Journal of Clinical Neuroscience, 14 (8), 737-741. doi: 10.1016/j.jocn.2006.03.021

Development and utilization of the patient knowledge questionnaire on Botulinum toxin use in movement disorders

2006

Journal Article

Charles Dickens: The man, medicine, and movement disorders

Schoffer, Kerrie L. and O'Sullivan, John D. (2006). Charles Dickens: The man, medicine, and movement disorders. Journal of Clinical Neuroscience, 13 (9), 898-901. doi: 10.1016/j.jocn.2005.12.035

Charles Dickens: The man, medicine, and movement disorders

2006

Journal Article

Congenital disorder of glycosylation type Ia presenting as early-onset cerebellar ataxia in an adult

Schoffer, Kerrie L., O'Sullivan, John D. and McGill, Jim (2006). Congenital disorder of glycosylation type Ia presenting as early-onset cerebellar ataxia in an adult. Movement Disorders, 21 (6), 869-872. doi: 10.1002/mds.20804

Congenital disorder of glycosylation type Ia presenting as early-onset cerebellar ataxia in an adult

2006

Journal Article

Cerebral Vasculitis in Ulcerative Colitis

Pandian, Jeyaraj Durai, Henderson, Robert D., O'Sullivan, John D. and Rajah, Thulasi (2006). Cerebral Vasculitis in Ulcerative Colitis. Archives of Neurology, 63 (5), 780-780. doi: 10.1001/archneur.63.5.780

Cerebral Vasculitis in Ulcerative Colitis

2006

Conference Publication

Assessing risk factors for depression in Parkinson’s disease

Dissanayaka, N., Selbach, A., Matheson, S., Marsh, R., Silburn, P. A., O'Sullivan, J. D., Byrne, G. J. and Mellick, G. D. (2006). Assessing risk factors for depression in Parkinson’s disease. 5th National Conference of Emerging Researchers in Aging, Sydney, Australia, 2006. Sydney, Australia: University of Sydney, Centre for Education and Research on Ageing.

Assessing risk factors for depression in Parkinson’s disease

2006

Conference Publication

Regular exposure to pesticides is related to depression associated with Parkinson's disease: evidence from two independent Australian samples

Dissanayaka, N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P., O’Sullivan, J., Byrne, G. and Mellick, G. (2006). Regular exposure to pesticides is related to depression associated with Parkinson's disease: evidence from two independent Australian samples. 2006 Eskitis Institute Graduate Student Symposium, Brisbane, QLD, Australia, November, 2006.

Regular exposure to pesticides is related to depression associated with Parkinson's disease: evidence from two independent Australian samples

2006

Conference Publication

Regular exposure to pesticides is related to depression associated with Parkinson's Disease: evidence from two independent Australian samples

Dissanayaka, N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P., O’Sullivan, J., Byrne, G. and Mellick, G. (2006). Regular exposure to pesticides is related to depression associated with Parkinson's Disease: evidence from two independent Australian samples. 5th International Congress on Mental Dysfunction in Parkinson's Disease, Amsterdam, Netherlands, 12-14 June, 2006. Camden, London, United Kingdom: Elsevier. doi: 10.1016/S1353-8020(07)70104-9

Regular exposure to pesticides is related to depression associated with Parkinson's Disease: evidence from two independent Australian samples

2006

Conference Publication

Assessing the risk factors for depression in Parkinson's disease

Dissanayaka, N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P., O’Sullivan, J., Byrne, G. and Mellick, G. (2006). Assessing the risk factors for depression in Parkinson's disease. ASMR Queensland Postgraduate Medical Research Student Conference, Brisbane, QLD, Australia, 26 May, 2006.

Assessing the risk factors for depression in Parkinson's disease

2006

Conference Publication

Validity of three depression rating scales in Australian Parkinson's Disease patients

Dissanayaka, N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P., O’Sullivan, J., Byrne, G. and Mellick, G. (2006). Validity of three depression rating scales in Australian Parkinson's Disease patients. 5th International Congress on Mental Dysfunction in Parkinson's Disease, Amsterdam, Netherlands, 12-14 June, 2006. Camden, London, United Kingdom: Elsevier. doi: 10.1016/S1353-8020(07)70108-6

Validity of three depression rating scales in Australian Parkinson's Disease patients

2006

Conference Publication

Validity of three depression rating scales in Australian Parkinson's disease patients

Dissanayaka, N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P., O’Sullivan, J., Byrne, G. and Mellick, G. (2006). Validity of three depression rating scales in Australian Parkinson's disease patients. 2006 Eskitis Institute Graduate Student Symposium, Brisbane, QLD, Australia, November, 2006.

Validity of three depression rating scales in Australian Parkinson's disease patients

2005

Journal Article

First case report of X linked dystonia parkinsonism (XDP) or 'lubag' in Australia

Plummer, C., Bradfield, J., Singleton, A. B., Hernandez, D., Singleton, A. A. and O'Sullivan, J. (2005). First case report of X linked dystonia parkinsonism (XDP) or 'lubag' in Australia. Journal of Clinical Neuroscience, 12 (8), 946-947. doi: 10.1016/j.jocn.2004.10.015

First case report of X linked dystonia parkinsonism (XDP) or 'lubag' in Australia

2005

Conference Publication

Circadian blood pressure variation after acute stroke

Pandian, J., Wong, A., Lincoln, D., Davis, J., Henderson, R., O'Sullivan, J. and Read, S. (2005). Circadian blood pressure variation after acute stroke. 18th World Congress of Neurology, Sydney, Australia, 5-11 November 2005. Amsterdam, Netherlands: Elsevier .

Circadian blood pressure variation after acute stroke

Funding

Current funding

  • 2024 - 2028
    A randomised controlled trial, of N-Acetyl Cysteine, for premanifest Huntingtin gene expansion carriers (NAC-preHD)
    Western Sydney Local Health District
    Open grant
  • 2023 - 2026
    A randomised controlled trial of N-Acetyl Cysteine for premanifest Huntington gene expansion carriers (NAC-preHD)
    Huntington's Australia Research Grant
    Open grant
  • 2023 - 2026
    Mining the gut microbiome to develop new treatments and biomarkers for Parkinson's disease
    Wesley Medical Research Ltd
    Open grant
  • 2023 - 2027
    Enhancing utility of neuropsychological evaluation for earlier and effective diagnosis of dementia in Parkinson's disease
    NHMRC MRFF Dementia, Ageing and Aged Care Mission
    Open grant
  • 2022 - 2025
    Mining the inflammasome-gut microbiome axis to uncover new biomarkers and therapeutic targets for Parkinson's disease
    Research Donation Generic
    Open grant
  • 2022 - 2025
    Validating Magnetic Resonance diagnosis in Parkinson's Disease
    Research Donation Generic
    Open grant
  • 2022 - 2026
    Gilchrist Family Parkinson's Research Program
    Research Donation Generic
    Open grant
  • 2020 - 2025
    Sodium Selenate as a Disease Modifying Treatment for Progressive Supranuclear Palsy (Sodium Selenate for PSP) (MRFF RCRDUN Neurological Disorders Grant administered by Monash University)
    Monash University
    Open grant

Past funding

  • 2024 - 2025
    Evaluation of noval disease-modifying therapeutics for Parkinson's disease (The Michael J. Fox Foundation for Parkinson's Research Project led by QUT)
    Queensland University of Technology
    Open grant
  • 2022 - 2024
    Evaluation of Tolebrutinib as a novel disease-modifying therapeutic for Parkinson's disease
    The Michael J Fox Foundation Therapeutic Pipeline Program
    Open grant
  • 2021 - 2023
    Comparative and Cross Validation of alpha- Synuclein Seeding Assays in Peripheral Biomatrices skin, submandibular gland, CSF, Saliva and Tear Fluids
    University of Georgia
    Open grant
  • 2021 - 2023
    Validating the functional role of the pathogenic microbiome metabolite Trimethylamine (TMA) at the gut-brain axis in Parkinson's disease
    The Michael J Fox Foundation for Parkinsons Research
    Open grant
  • 2021 - 2022
    Uncovering a novel therapeutic target to reduce dementia risk in Parkinson's disease
    Metro North Hospital and Health Service
    Open grant
  • 2021 - 2022
    Uncovering a novel therapeutic target to reduce dementia risk in Parkinson's disease (TRIP study)
    Metro North Hospital and Health Service
    Open grant
  • 2019 - 2022
    A randomised placebo-controlled crossover trial of micronised resveratrol as a treatment for Friedreich ataxia
    Murdoch Childrens Research Institute
    Open grant
  • 2019 - 2022
    Pharmacological targeting of inflammasome activation mechanisms in synuclein models of Parkinson's disease
    The Michael J Fox Foundation for Parkinsons Research
    Open grant
  • 2018 - 2019
    Targeting peripheral inflammatory pathology in Parkinson's disease using repurposed drugs
    Wesley Medical Research Ltd
    Open grant
  • 2018 - 2023
    A randomised controlled trial, of N-Acetyl Cysteine, for premanifest Huntingtin gene expansion carriers (NAC-preHD) (MRFF LCTRC administered by University of Sydney)
    University of Sydney
    Open grant
  • 2018
    Sleep measurements in Friedreich's ataxia, Huntington's disease patients and healthy volunteers
    Wesley Medical Research Ltd
    Open grant
  • 2018 - 2019
    Virtual reality innovation to treat anxiety in patients with cognitive impairment and Parkinson's Disease
    Metro North Hospital and Health Service
    Open grant
  • 2017 - 2019
    Therapeutic switching of a licensed oncology drug to target neuropathology in Parkinson's disease
    The Cure Parkinson's Trust
    Open grant
  • 2017 - 2019
    Defining inflammatory biomarkers in motor neuron disease patients to assist in clinical trial efficiency of the C5aR antagonist PMX205
    Wesley Medical Research Ltd
    Open grant
  • 2017 - 2023
    The Queensland Drug Repurposing Initiative
    Queensland Government Advance Queensland Innovation Partnerships
    Open grant
  • 2016 - 2018
    Pharmacological Targeting of Proinflammatory Kinase Signalling in Parkinson's disease
    The Michael J Fox Foundation for Parkinsons Research
    Open grant
  • 2016 - 2017
    Cognitive behaviour therapy for anxiety in Parkinson's disease: outcomes for patients and caregivers
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2015 - 2017
    Complement activation as a therapeutic target and clinical biomarker for Parkinson's disease
    NHMRC Project Grant
    Open grant
  • 2015 - 2016
    Mindfulness therapy for depression, anxiety, motor and cognitive dysfunction in Parkinson's disease
    Royal Brisbane and Women's Hospital
    Open grant
  • 2014 - 2016
    Developing a non-invasive composite measure to enhance accuracy of identifying anxiety in Parkinson's disease
    Royal Brisbane and Women's Hospital
    Open grant
  • 2013 - 2014
    Characterising anxiety in Parkinson's disease: A psycholinguistic and psychophysiology study comparing to anxious older adults
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2012 - 2013
    Improving diagnostic methods of anxiety disorders in Parkinson's disease: Phase 2
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2011 - 2013
    Therapeutic Targeting of Complement C5a Receptors in Huntington's Disease
    NHMRC Project Grant
    Open grant

Supervision

Availability

Associate Professor John O'Sullivan is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Master Philosophy

    Digital symptom tracking - using digital tools for measuring and tracking motor, cognitive, and speech changes

    Associate Advisor

  • Doctor Philosophy

    The evolution of cognitive deficits in Lewy body disorders and related degenerative diseases.

    Associate Advisor

    Other advisors: Professor Peter Nestor

Completed supervision

Media

Enquiries

Contact Associate Professor John O'Sullivan directly for media enquiries about:

  • Botulinum toxin
  • Dystonia
  • Huntington's disease
  • Movement disorders
  • Parkinson's disease

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au